Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Prognostic values of mid-radiotherapy 18F-FDG PET/CT in patients with esophageal cancer.

Kim N, Cho H, Yun M, Park KR, Lee CG.

Radiat Oncol. 2019 Feb 4;14(1):27. doi: 10.1186/s13014-019-1232-1.

2.

Prognostic value of 18 F-FDG PET/CT parameters in patients who undergo salvage treatments for recurrent squamous cell carcinoma of the larynx and hypopharynx.

Lee JR, Almuhaimid TM, Roh JL, Oh JS, Kim SJ, Kim JS, Choi SH, Nam SY, Kim SY.

J Surg Oncol. 2018 Sep;118(4):644-650. doi: 10.1002/jso.25185. Epub 2018 Aug 21.

PMID:
30132891
3.

Stereotactic Ablative Radiation Therapy for Lung Oligometastases: Predictive Parameters of Early Response by 18FDG-PET/CT.

Mazzola R, Fiorentino A, Di Paola G, Giaj Levra N, Ricchetti F, Fersino S, Tebano U, Pasetto S, Ruggieri R, Salgarello M, Alongi F.

J Thorac Oncol. 2017 Mar;12(3):547-555. doi: 10.1016/j.jtho.2016.11.2234. Epub 2017 Jan 24.

4.

18F-deoxyglucose positron emission tomography/computed tomography to predict local failure in esophageal squamous cell carcinoma.

Fan B, Fan P, Kong L, Sun X, Zhao S, Sun X, Fu Z, Zheng J, Ma L, Wang S, Hu M, Yu J.

Oncotarget. 2017 May 23;8(21):34498-34506. doi: 10.18632/oncotarget.15606.

5.

(18F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy.

Scher N, Castelli J, Depeursinge A, Bourhis J, Prior JO, Herrera FG, Ozsahin M.

Cancer Radiother. 2018 May;22(3):229-235. doi: 10.1016/j.canrad.2017.10.003. Epub 2018 Apr 9.

PMID:
29650390
7.

Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.

Lin P, Min M, Lee M, Holloway L, Forstner D, Bray V, Fowler A.

Eur J Nucl Med Mol Imaging. 2017 May;44(5):801-811. doi: 10.1007/s00259-016-3584-1. Epub 2016 Dec 21.

PMID:
28004135
8.

Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.

Hyun SH, Choi JY, Shim YM, Kim K, Lee SJ, Cho YS, Lee JY, Lee KH, Kim BT.

Ann Surg Oncol. 2010 Jan;17(1):115-22. doi: 10.1245/s10434-009-0719-7. Epub 2009 Oct 14.

PMID:
19826877
9.

Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.

Kim JW, Oh JS, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY.

Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1353-61. doi: 10.1007/s00259-015-3051-4. Epub 2015 Jun 12.

PMID:
26067088
10.

FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes.

Mapelli P, Broggi S, Incerti E, Alongi P, Kirienko M, Fiorino C, Dell Oca I, Fallanca F, Vanoli EG, Di Muzio NG, Gianolli L, Picchio M.

Curr Radiopharm. 2017 Aug 24;10(2):102-110. doi: 10.2174/1874471010666170413151108.

PMID:
28412923
11.

3'-deoxy-3'-[¹⁸F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancer: comparison with [¹⁸F]-FDG PET/CT.

Chen H, Li Y, Wu H, Sun L, Lin Q, Zhao L, An H.

Strahlenther Onkol. 2015 Feb;191(2):141-52. doi: 10.1007/s00066-014-0744-8. Epub 2014 Aug 28.

PMID:
25163419
12.

Texture analysis of 18F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy.

Nakajo M, Jinguji M, Nakabeppu Y, Nakajo M, Higashi R, Fukukura Y, Sasaki K, Uchikado Y, Natsugoe S, Yoshiura T.

Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):206-214. doi: 10.1007/s00259-016-3506-2. Epub 2016 Sep 10.

PMID:
27613542
13.

Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.

Im HJ, Oo S, Jung W, Jang JY, Kim SW, Cheon GJ, Kang KW, Chung JK, Kim EE, Lee DS.

Medicine (Baltimore). 2016 May;95(19):e3686. doi: 10.1097/MD.0000000000003686.

14.

18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.

Lim R, Eaton A, Lee NY, Setton J, Ohri N, Rao S, Wong R, Fury M, Schöder H.

J Nucl Med. 2012 Oct;53(10):1506-13. doi: 10.2967/jnumed.111.101402. Epub 2012 Aug 14.

15.

Utility of 18F-FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma following Chemoradiation.

Arnett ALH, Merrell KW, Macintosh EM, James SE, Nathan MA, Shen KR, Ravi K, Neben Wittich MA, Haddock MG, Hallemeier CL.

J Thorac Oncol. 2017 Jan;12(1):121-128. doi: 10.1016/j.jtho.2016.08.136. Epub 2016 Aug 26.

16.

Lymph node standardized uptake values at pre-treatment 18F-fluorodeoxyglucose positron emission tomography as a valuable prognostic factor for distant metastasis in nasopharyngeal carcinoma.

Jeong Y, Baek S, Park JW, Joo JH, Kim JS, Lee SW.

Br J Radiol. 2017 Mar;90(1071):20160239. doi: 10.1259/bjr.20160239. Epub 2016 Dec 23.

17.

Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.

Lee JW, Na JO, Kang DY, Lee SY, Lee SM.

Clin Lung Cancer. 2017 Mar;18(2):198-206. doi: 10.1016/j.cllc.2016.07.001. Epub 2016 Jul 9.

PMID:
27495385
18.
19.

Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer.

Leseur J, Roman-Jimenez G, Devillers A, Ospina-Arango JD, Williaume D, Castelli J, Terve P, Lavoue V, Garin E, Lejeune F, Acosta O, De Crevoisier R.

Radiother Oncol. 2016 Sep;120(3):512-518. doi: 10.1016/j.radonc.2016.08.008. Epub 2016 Aug 25.

PMID:
27569847
20.

Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation.

Li Y, Zschaeck S, Lin Q, Chen S, Chen L, Wu H.

Radiat Oncol. 2019 Feb 19;14(1):35. doi: 10.1186/s13014-019-1236-x.

Supplemental Content

Support Center